Evidence map›Paper›PMID 41107634›Full record

ArticleJournal of neurology2025

Pedigree analysis and genetic inheritance of fatal familial insomnia (FFI) in a Portuguese multigenerational family.

Angela Da Silva Correia, Ines Laginha, Susana Guimaraes, Kathrin Dittmar, Matthias Schmitz, Joaquin Castilla, Inga Zerr, Susana Da Silva Correia

Abstract read
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angela Da Silva Correia *Department of Neurology, University Medical Center and the German Center for Neurodegenerative Diseases (DZNE), Georg-August University, Goettingen, Germany. angela.silva-correia@med.uni-goettingen.de.ORCID http://orcid.org/0000-0003-1903-7172
Ines Laginha *Department of Neurology, University Medical Center and the German Center for Neurodegenerative Diseases (DZNE), Georg-August University, Goettingen, Germany.
Susana GuimaraesHigh-Risk Autopsy Unit, Biosafety Level 3(BSL-3), Department of Pathology, ULSSJoão, Porto, Portugal.
Kathrin DittmarDepartment of Neurology, University Medical Center and the German Center for Neurodegenerative Diseases (DZNE), Georg-August University, Goettingen, Germany.
Matthias SchmitzDepartment of Neurology, University Medical Center and the German Center for Neurodegenerative Diseases (DZNE), Georg-August University, Goettingen, Germany.
Joaquin CastillaCentro de Investigación Cooperativa en Biociencias (CIC BioGUNE), Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
Inga Zerr *Department of Neurology, University Medical Center and the German Center for Neurodegenerative Diseases (DZNE), Georg-August University, Goettingen, Germany.
Susana Da Silva Correia *Department of Neurology, University Medical Center and the German Center for Neurodegenerative Diseases (DZNE), Georg-August University, Goettingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatal familial insomnia (FFI) is a rare, autosomal dominant prion disease caused by a mutation in the PRNP gene, leading to the misfolding of the cellular prion protein (PrPC) into its pathogenic form (PrPSc). This results in neurodegeneration, particularly in the thalamus, a key region regulating sleep-wake cycles, which underlies the hallmark symptoms of FFI, including insomnia, autonomic dysfunctions, motor disturbances and cognitive decline. This study focuses on a Portuguese family with FFI, providing a detailed pedigree analysis spanning five generations and comprising 134 individuals, to elucidate inheritance patterns, disease onset, and clinical progression. The findings confirm the autosomal-dominant inheritance pattern and a strong familial clustering of the disease with age of onset in the late 50s (mean 57 years). Although 67% of affected individuals succumbing to the disease within months to 1.5 years, a notably 33% exhibited prolonged survival beyond the typical disease duration, exceeding proportions reported in the literature. Family members retrospectively reported prodromal symptoms, including generalized pain, headaches, tinnitus, pruritus, and behavioral changes, occurring up to five years before diagnosis. In several cases, reportedly, disease onset was associated with major phycological stressors (e.g., emotional stress or mourning). While the significance of these observations remains uncertain, they may provide insights into potential early features in this kindred. Further research integrating genomic sequencing, biomarkers, and longitudinal clinical assessments are needed to better understand the mechanisms underlying the heterogeneity of FFI and to explore potential therapeutic interventions.

Indexed as

Insomnia, Fatal FamilialAdultAgedAge of OnsetDisease ProgressionExtended FamilyFemaleHumansMaleMiddle AgedPedigreePortugalPrion ProteinsPrion ProteinsPRNP protein, humanFatal familial insomniaFFIPortugalPrion diseasesPrPCPrPSc

Identifiers

PMID41107634
PMCPMC12534306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.